GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Welcia Holdings Co Ltd (TSE:3141) » Definitions » EV-to-EBIT

Welcia Holdings Co (TSE:3141) EV-to-EBIT : 12.89 (As of Apr. 25, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Welcia Holdings Co EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Welcia Holdings Co's Enterprise Value is 円529,391 Mil. Welcia Holdings Co's EBIT for the trailing twelve months (TTM) ended in Nov. 2023 was 円41,056 Mil. Therefore, Welcia Holdings Co's EV-to-EBIT for today is 12.89.

The historical rank and industry rank for Welcia Holdings Co's EV-to-EBIT or its related term are showing as below:

TSE:3141' s EV-to-EBIT Range Over the Past 10 Years
Min: 6.31   Med: 16.97   Max: 26.17
Current: 12.89

During the past 13 years, the highest EV-to-EBIT of Welcia Holdings Co was 26.17. The lowest was 6.31. And the median was 16.97.

TSE:3141's EV-to-EBIT is ranked better than
67.52% of 428 companies
in the Healthcare Providers & Services industry
Industry Median: 18.5 vs TSE:3141: 12.89

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Welcia Holdings Co's Enterprise Value for the quarter that ended in Nov. 2023 was 円595,758 Mil. Welcia Holdings Co's EBIT for the trailing twelve months (TTM) ended in Nov. 2023 was 円41,056 Mil. Welcia Holdings Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Nov. 2023 was 6.89%.


Welcia Holdings Co EV-to-EBIT Historical Data

The historical data trend for Welcia Holdings Co's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Welcia Holdings Co EV-to-EBIT Chart

Welcia Holdings Co Annual Data
Trend Aug14 Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.71 16.88 15.96 15.12 15.65

Welcia Holdings Co Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.12 15.63 14.03 13.49 -

Competitive Comparison of Welcia Holdings Co's EV-to-EBIT

For the Pharmaceutical Retailers subindustry, Welcia Holdings Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Welcia Holdings Co's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Welcia Holdings Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Welcia Holdings Co's EV-to-EBIT falls into.



Welcia Holdings Co EV-to-EBIT Calculation

Welcia Holdings Co's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=529391.104/41056
=12.89

Welcia Holdings Co's current Enterprise Value is 円529,391 Mil.
Welcia Holdings Co's EBIT for the trailing twelve months (TTM) ended in Nov. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円41,056 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Welcia Holdings Co  (TSE:3141) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Welcia Holdings Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Nov. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Nov. 2023 ) =EBIT / Enterprise Value (Q: Nov. 2023 )
=41056/595757.728
=6.89 %

Welcia Holdings Co's Enterprise Value for the quarter that ended in Nov. 2023 was 円595,758 Mil.
Welcia Holdings Co's EBIT for the trailing twelve months (TTM) ended in Nov. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円41,056 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Welcia Holdings Co EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Welcia Holdings Co's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Welcia Holdings Co (TSE:3141) Business Description

Traded in Other Exchanges
Address
2-2-15 Outside Kanda, Chiyoda-ku, Tokyo, JPN, 101-0021
Welcia Holdings Co Ltd operates drug retail stores that sell pharmaceuticals, health and beauty products, baby supplies, health supplements, sanitation items, groceries, and personal-care products. The company generates the bulk of its revenue through sales of over-the-counter drugs and food products. Welcia is involved in pharmaceutical dispensing, blood testing, and earthquake reconstruction assistance. The highest concentration of sales remains in the Kanto region of Japan. Welcia also provides nursing services through its long-term care enterprise.

Welcia Holdings Co (TSE:3141) Headlines

No Headlines